VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
INTSIntensity Therapeutics, Inc.
$4.10$104M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksINTSQuarterly Balance Sheet

Intensity Therapeutics, Inc. (INTS) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Intensity Therapeutics, Inc. (INTS) quarterly balance sheet — complete assets, liabilities & equity history

INTS Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Total Current Assets10.91M12.71M8.19M3.04M1.65M3.36M3.79M7.44M11.17M15.46M16.63M18.06M
Cash & Short-Term Investments10.24M11.92M7.07M2.22M929K2.59M2.78M6.32M10.5M14.78M15.65M135.76K
Cash Only10.24M11.92M7.07M2.22M929K2.59M2.78M3.24M7.46M8.56M6.69M135.76K
Short-Term Investments00000003.08M3.04M6.22M8.96M0
Accounts Receivable000000000014.37K17.84M
Days Sales Outstanding------------
Inventory000000000000
Days Inventory Outstanding------------
Other Current Assets661K01.12M00001.12M0005.58K
Total Non-Current Assets1.39M1.39M1.4M1.41M1.41M1.42M1.43M1.23M1.24M1.83M181.04K167.74K
Property, Plant & Equipment89K96K103K109K116K122K128K135K141K147K152.6K0
Fixed Asset Turnover------------
Goodwill000000000000
Intangible Assets000000000000
Long-Term Investments000000000000
Other Non-Current Assets1.3M1.3M1.3M1.3M1.3M1.3M1.3M1.1M1.1M1.68M28.44K167.74K
Total Assets12.29M14.1M9.59M4.44M3.06M4.78M5.21M8.67M12.41M17.3M16.82M18.23M
Asset Turnover------------
Asset Growth %301.01%194.81%83.87%-48.77%-75.3%-72.34%-69%-52.42%1204.06%884.35%1295.41%701.46%
Total Current Liabilities2.24M2.15M2.28M2.16M2.63M1.75M2.32M3.2M2.52M3.96M723.97K3.06M
Accounts Payable636K583K1.68M1.19M1.59M1.22M540K1.92M1.22M3.05M358.4K1.58M
Days Payables Outstanding7.84K-------32.36K--2.92K
Short-Term Debt32K31K31K000000000
Deferred Revenue (Current)000000000000
Other Current Liabilities1.57M1.53M561K43K056K616K419K0392K01.05M
Current Ratio4.86x5.92x3.60x1.40x0.63x1.92x1.63x2.32x4.43x3.91x22.98x5.91x
Quick Ratio4.86x5.92x3.60x1.40x0.63x1.92x1.63x2.32x4.43x3.91x22.98x5.91x
Cash Conversion Cycle------------
Total Non-Current Liabilities70K79K87K95K102K110K117K124K167K174K180.89K36K
Long-Term Debt70K79K87K000000000
Capital Lease Obligations00095K102K110K117K124K131K138K144.89K0
Deferred Tax Liabilities000000000000
Other Non-Current Liabilities0000000036K36K36K36K
Total Liabilities2.31M2.23M2.36M2.26M2.73M1.86M2.43M3.33M2.69M4.13M904.86K3.09M
Total Debt102K110K118K125K131K138K145K151K157K158K155.45K0
Net Debt-10.14M-11.81M-6.95M-2.09M-798K-2.45M-2.64M-3.09M-7.3M-8.4M-6.54M-135.76K
Debt / Equity0.01x0.01x0.02x0.06x0.39x0.05x0.05x0.03x0.02x0.01x0.01x-
Debt / EBITDA------------
Net Debt / EBITDA------------
Interest Coverage------------15.69x
Total Equity9.98M11.88M7.22M2.18M334K2.92M2.78M5.34M9.72M13.16M15.91M15.13M
Equity Growth %2887.72%306.99%159.88%-59.14%-96.56%-77.83%-82.53%-64.68%160.91%187.18%477.54%221.26%
Book Value per Share0.390.884.192.890.555.075.039.7517.7323.9029.12107.59
Total Shareholders' Equity9.98M11.88M7.22M2.18M334K2.92M2.78M5.34M9.72M13.16M15.91M15.13M
Common Stock005K3K2K2K1K1K1K1K1.37K1.31K
Retained Earnings-80.82M-78.39M-75.34M-72.67M-70.13M-66.78M-63.6M-60.09M-55.12M-50.52M-47.34M-43.69M
Treasury Stock000000000000
Accumulated OCI000000000000
Minority Interest000000000000